{"id":443,"date":"2019-12-09T14:14:03","date_gmt":"2019-12-09T14:14:03","guid":{"rendered":"http:\/\/events.marketsandmarkets.com\/blog\/?p=443"},"modified":"2019-12-09T14:19:20","modified_gmt":"2019-12-09T14:19:20","slug":"what-do-mnm-analysts-have-to-say-about-the-immuno-oncology-market","status":"publish","type":"post","link":"https:\/\/events.marketsandmarkets.com\/blog\/what-do-mnm-analysts-have-to-say-about-the-immuno-oncology-market\/","title":{"rendered":"What do MNM Analysts have to say about the Immuno Oncology Market?"},"content":{"rendered":"\n<p><strong>Our <a href=\"https:\/\/events.marketsandmarkets.com\/4th-annual-marketsandmarkets-next-gen-immuno-oncology-congress\/\">4th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress<\/a> to be held on 12th-13th March 2020 in London, UK would address the challenges and future directions in IO research. The congress aims to<\/strong>&nbsp;bring academicians, researchers and scientists from research institutes, pharmaceutical,&nbsp;bio-pharmaceutical,&nbsp;and biotechnology companies to discuss the latest updates in the development of&nbsp;<strong>ADC\u2019s, Bispecific Antibodies, Cellular Therapy, and Immune Checkpoint Inhibitors<\/strong>. This congress would also focus on various&nbsp;<strong><em>combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy<\/em><\/strong>. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. <\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter\"><img loading=\"lazy\" width=\"469\" height=\"1024\" src=\"https:\/\/events.marketsandmarkets.com\/blog\/wp-content\/uploads\/2019\/12\/Immunoncology-Market_V4-469x1024.jpg\" alt=\"\" class=\"wp-image-445\" srcset=\"https:\/\/events.marketsandmarkets.com\/blog\/wp-content\/uploads\/2019\/12\/Immunoncology-Market_V4-469x1024.jpg 469w, https:\/\/events.marketsandmarkets.com\/blog\/wp-content\/uploads\/2019\/12\/Immunoncology-Market_V4-69x150.jpg 69w, https:\/\/events.marketsandmarkets.com\/blog\/wp-content\/uploads\/2019\/12\/Immunoncology-Market_V4-320x700.jpg 320w, https:\/\/events.marketsandmarkets.com\/blog\/wp-content\/uploads\/2019\/12\/Immunoncology-Market_V4-768x1678.jpg 768w, https:\/\/events.marketsandmarkets.com\/blog\/wp-content\/uploads\/2019\/12\/Immunoncology-Market_V4.jpg 1400w\" sizes=\"(max-width: 469px) 100vw, 469px\" \/><\/figure><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Our 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress to be held on 12th-13th March 2020 in London, UK would address the challenges and future directions in IO research. The congress aims to&nbsp;bring academicians, researchers and scientists from research institutes, pharmaceutical,&nbsp;bio-pharmaceutical,&nbsp;and biotechnology companies to discuss the latest updates in the development of&nbsp;ADC\u2019s, Bispecific Antibodies, Cellular Therapy, and Immune Checkpoint Inhibitors. This congress would also focus on various&nbsp;combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case&#8230;<\/p>\n","protected":false},"author":2,"featured_media":450,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[170,17,179,178,177,171,145,176,173,159,172,121,175,174],"_links":{"self":[{"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/posts\/443"}],"collection":[{"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/comments?post=443"}],"version-history":[{"count":3,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/posts\/443\/revisions"}],"predecessor-version":[{"id":449,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/posts\/443\/revisions\/449"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/media\/450"}],"wp:attachment":[{"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/media?parent=443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/categories?post=443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/tags?post=443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}